As of the latest Form 4 filed Jul 1, 2026.
What Limoneira Co insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 14 most recent filings for LMNR.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | 2026-07-01 | Hamm Gregory C. VP, CFO and Treasurer | SSale | −1.00K | $13.05 | $13.1K | Yes (planned) | Form 4 ↗ |
| 2026-06-02 | 2026-06-01 | Hamm Gregory C. VP, CFO and Treasurer | SSale | −1.00K | $12.77 | $12.8K | Yes (planned) | Form 4 ↗ |
| 2026-05-05 | 2026-05-01 | Hamm Gregory C. VP, CFO and Treasurer | SSale | −1.00K | $12.78 | $12.8K | Yes (planned) | Form 4 ↗ |
| 2026-03-26 | 2026-03-25 | Slater Scott S Director | AAward | +6.32K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-26 | 2026-03-25 | Mora Elizabeth Director | AAward | −6.32K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-26 | 2026-03-25 | TERRY EDGAR A. Director | AAward | +6.32K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-26 | 2026-03-25 | Carbone Barbara Director | AAward | −6.32K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-26 | 2026-03-25 | Kimball Gordon E Director | AAward | +6.32K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-26 | 2026-03-25 | NOLAN PETER J Director | AAward | −6.32K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-09 | 2026-01-08 | Slater Scott S Director | PPurchase | +5.00K | $12.85 | $64.3K | No | Form 4 ↗ |
| 2025-12-29 | 2025-12-22 | PALAMOUNTAIN MARK EVP, CFO and Treasurer | FTax | −3.75K | $14.40 | $53.9K | No | Form 4 ↗ |
| 2025-12-29 | 2025-12-22 | Edwards Harold S President and CEO | FTax | −6.15K | $14.40 | $88.6K | No | Form 4 ↗ |
| 2025-12-22 | 2025-12-18 | Edwards Harold S President and CEO | FTax | −3.37K | $14.95 | $50.4K | No | Form 4 ↗ |
| 2025-12-22 | 2025-12-18 | PALAMOUNTAIN MARK EVP, CFO and Treasurer | FTax | −2.33K | $14.95 | $34.9K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also LMNR’s full analysis or the market-wide insider trading feed. The tabs above jump to LMNR’s other SEC data.
Source: SEC Form 4 filings for LMNR, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.